Rajat Thawani, Assistant Professor, University of Chicago, shared a post by Physician’s Weekly on X, adding:
“Talking about biomarkers in lung cancer. Every patients deserves testing to determine the right treatment.”
Quoting Physician’s Weekly:
“In today’s PeerPOV podcast, Rajat Thawani of University of Chicago Hematology/Oncology discusses the role of specialized biomarker testing teams & why biomarker testing is crucial in guiding treatment decisions for patients with ROS1 mutations in NSCLC. Tune in here.”
Source: Rajat Thawani/X and Physician’s Weekly/X